NPI: 1710909585 · JACKSON, MS 39202 · General Acute Care Hospital · NPI assigned 07/24/2006
Authorized official DUCKETT, GREGORY controls 20+ related entities in our dataset. Read more
| Authorized Official | DUCKETT, GREGORY (SR VP/ CLO) |
| Parent Organization | BAPTIST MEMORIAL HEALTH CARE CORP. |
| NPI Enumeration Date | 07/24/2006 |
Other providers sharing the same authorized official: DUCKETT, GREGORY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 222,794 | $6.03M |
| 2019 | 231,362 | $6.44M |
| 2020 | 193,634 | $5.19M |
| 2021 | 238,845 | $6.02M |
| 2022 | 278,811 | $6.44M |
| 2023 | 242,943 | $6.42M |
| 2024 | 197,109 | $5.51M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 35,068 | 29,327 | $4.33M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 25,929 | 21,546 | $3.93M |
| G0378 | Hospital observation service, per hour | 8,724 | 5,656 | $2.90M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 13,439 | 11,245 | $2.33M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 16,987 | 13,907 | $1.28M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 15,627 | 13,212 | $1.21M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 9,354 | 7,784 | $1.06M |
| J9271 | Injection, pembrolizumab, 1 mg | 492 | 242 | $1.01M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 7,441 | 6,213 | $913K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 8,841 | 3,902 | $876K |
| 78815 | Positron emission tomography (PET) for limited area imaging | 2,371 | 2,005 | $828K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 18,709 | 15,291 | $804K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 26,338 | 17,574 | $790K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 9,247 | 5,189 | $595K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 1,323 | 1,159 | $591K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 8,544 | 6,274 | $590K |
| 96361 | Intravenous infusion, hydration; each additional hour | 8,566 | 5,101 | $570K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 34,512 | 26,764 | $554K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 5,871 | 2,830 | $551K |
| 71045 | Radiologic examination, chest; single view | 17,885 | 14,170 | $539K |
| 71046 | Radiologic examination, chest; 2 views | 15,246 | 12,879 | $537K |
| 78431 | 1,036 | 823 | $525K | |
| 80053 | Comprehensive metabolic panel | 69,158 | 53,833 | $447K |
| 86900 | 10,500 | 7,950 | $417K | |
| D7140 | Extraction, erupted tooth or exposed root | 1,170 | 288 | $415K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1,220 | 1,012 | $389K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 47,647 | 34,630 | $368K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 5,015 | 4,246 | $337K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 11,007 | 8,746 | $324K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 8,333 | 4,850 | $320K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 23,696 | 20,639 | $290K |
| 96375 | Therapeutic injection; each additional sequential IV push | 14,020 | 10,064 | $283K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 3,513 | 2,955 | $281K |
| 95811 | 739 | 629 | $278K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 65,630 | 48,823 | $276K |
| 96367 | 6,890 | 3,232 | $262K | |
| 70450 | Computed tomography, head or brain; without contrast material | 6,824 | 5,613 | $260K |
| 88307 | 2,190 | 1,266 | $245K | |
| D2930 | Prefabricated stainless steel crown - primary tooth | 3,862 | 487 | $240K |
| 47563 | 120 | 91 | $229K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 20,748 | 8,967 | $209K |
| 86850 | 10,667 | 8,056 | $204K | |
| J2357 | Injection, omalizumab, 5 mg | 563 | 198 | $188K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 6,948 | 6,025 | $188K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 6,945 | 6,017 | $186K |
| 36415 | Collection of venous blood by venipuncture | 103,973 | 70,330 | $186K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 2,898 | 2,365 | $183K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 1,381 | 1,126 | $177K |
| 83880 | 9,799 | 7,893 | $176K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 13,128 | 10,765 | $176K |
| 11043 | 1,283 | 592 | $161K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 3,902 | 3,264 | $160K |
| 84443 | Thyroid stimulating hormone (TSH) | 16,039 | 13,505 | $150K |
| 78492 | 455 | 409 | $149K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 3,466 | 1,799 | $146K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1,723 | 1,476 | $145K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 9,420 | 8,016 | $142K |
| 93017 | 2,747 | 2,300 | $141K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 2,597 | 2,293 | $137K |
| J2469 | Injection, palonosetron hcl, 25 mcg | 4,672 | 2,124 | $132K |
| 86901 | 10,553 | 7,957 | $127K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3,672 | 3,271 | $126K |
| 74018 | 3,249 | 2,611 | $123K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 2,033 | 1,793 | $121K |
| 88342 | 2,903 | 1,704 | $121K | |
| 81025 | 19,943 | 16,441 | $119K | |
| J1453 | Injection, fosaprepitant, 1 mg | 2,361 | 1,104 | $115K |
| 80048 | Basic metabolic panel (calcium, ionized) | 23,652 | 16,924 | $108K |
| 76801 | 1,566 | 1,269 | $105K | |
| 86922 | 2,792 | 1,029 | $105K | |
| 80061 | Lipid panel | 13,238 | 11,103 | $102K |
| 73560 | 3,006 | 2,442 | $99K | |
| 36430 | 1,143 | 720 | $98K | |
| 81001 | 44,565 | 36,277 | $96K | |
| 84484 | 15,597 | 9,721 | $96K | |
| 93923 | 3,026 | 2,298 | $95K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 15,041 | 12,738 | $81K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 1,137 | 999 | $81K |
| 96417 | 3,142 | 1,548 | $78K | |
| 96415 | 2,734 | 1,366 | $77K | |
| 76642 | 2,314 | 1,910 | $76K | |
| 72100 | 1,790 | 1,469 | $75K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 4,356 | 3,646 | $74K |
| 93970 | 1,358 | 1,129 | $74K | |
| 71250 | 2,477 | 2,105 | $73K | |
| 85027 | 19,905 | 14,105 | $71K | |
| P9016 | Red blood cells, leukocytes reduced, each unit | 965 | 585 | $70K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 197 | 177 | $70K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 443 | 388 | $65K |
| 83036 | Hemoglobin; glycosylated (A1C) | 15,216 | 12,351 | $65K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2,405 | 1,490 | $64K |
| 88304 | 2,747 | 2,006 | $63K | |
| 93971 | 2,097 | 1,694 | $62K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 949 | 839 | $61K |
| 73030 | 1,888 | 1,553 | $56K | |
| 73630 | 1,569 | 1,348 | $56K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 4,691 | 4,089 | $55K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 1,141 | 981 | $55K |
| Q5111 | Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg | 206 | 116 | $55K |
| 77065 | Tomosynthesis, mammo | 1,671 | 1,227 | $54K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 254 | 202 | $51K |
| 93880 | 1,200 | 917 | $50K | |
| 73610 | 1,215 | 1,010 | $46K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 102 | 86 | $45K |
| 73130 | 1,036 | 879 | $43K | |
| 88312 | 1,798 | 1,057 | $43K | |
| 83970 | 2,317 | 1,798 | $43K | |
| 77412 | 656 | 61 | $42K | |
| 87186 | 8,309 | 5,861 | $42K | |
| 10060 | 414 | 361 | $38K | |
| 83690 | 8,650 | 6,900 | $37K | |
| 73502 | 1,469 | 1,171 | $36K | |
| 77066 | Tomosynthesis, mammo | 742 | 581 | $36K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 463 | 397 | $33K |
| 36830 | 46 | 40 | $33K | |
| 84702 | 2,913 | 2,293 | $31K | |
| 82607 | 4,323 | 3,554 | $31K | |
| 87070 | 5,946 | 4,666 | $31K | |
| 82565 | 11,446 | 9,429 | $30K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 443 | 346 | $30K |
| 82550 | 5,962 | 4,346 | $29K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 527 | 455 | $28K |
| 86140 | 10,699 | 8,192 | $28K | |
| 82728 | 4,144 | 3,378 | $28K | |
| 93296 | 2,754 | 2,474 | $28K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1,395 | 1,177 | $27K |
| 97162 | 1,506 | 1,120 | $27K | |
| 82553 | 3,587 | 2,707 | $27K | |
| 84439 | 4,614 | 3,969 | $26K | |
| 76536 | 700 | 586 | $26K | |
| 36600 | 1,106 | 878 | $26K | |
| 80074 | 1,008 | 811 | $26K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | 229 | 183 | $26K |
| 83735 | 7,220 | 4,786 | $26K | |
| 86480 | 849 | 718 | $24K | |
| 87040 | 4,411 | 2,010 | $24K | |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 111 | 55 | $23K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 78 | 70 | $22K |
| 82803 | 1,807 | 1,343 | $21K | |
| 87147 | 6,176 | 3,216 | $21K | |
| 85610 | 10,098 | 7,492 | $21K | |
| 87077 | 4,317 | 3,045 | $20K | |
| 77334 | 167 | 90 | $19K | |
| 94060 | 255 | 211 | $19K | |
| Q5120 | Injection, pegfilgrastim-bmez (ziextenzo), biosimilar, 0.5 mg | 24 | 12 | $19K |
| 82746 | 2,842 | 2,345 | $19K | |
| 85007 | 8,613 | 6,271 | $19K | |
| 86235 | 2,747 | 451 | $18K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 734 | 600 | $17K |
| 77290 | 142 | 48 | $17K | |
| 85379 | 2,872 | 2,374 | $16K | |
| 78306 | 99 | 90 | $15K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 592 | 508 | $15K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 68 | 68 | $15K |
| 83605 | 2,634 | 1,964 | $15K | |
| 83550 | 3,606 | 2,996 | $15K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 677 | 633 | $14K |
| 84703 | 2,770 | 2,219 | $14K | |
| 86038 | 1,937 | 1,559 | $14K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 22,775 | 16,373 | $14K |
| 78264 | 75 | 62 | $14K | |
| 86592 | 4,472 | 3,812 | $13K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 798 | 656 | $13K |
| D0272 | Bitewings - two radiographic images | 13 | 12 | $13K |
| 70486 | 258 | 214 | $13K | |
| 73221 | 111 | 103 | $13K | |
| 82570 | 5,013 | 3,999 | $13K | |
| 84132 | 5,579 | 4,098 | $12K | |
| 77370 | 223 | 104 | $12K | |
| 94726 | 231 | 193 | $12K | |
| 87807 | 1,082 | 1,019 | $12K | |
| 87210 | 3,212 | 2,805 | $12K | |
| 82375 | 1,800 | 1,340 | $12K | |
| 83540 | 3,709 | 3,088 | $12K | |
| 85652 | 7,952 | 6,538 | $11K | |
| 83655 | 1,283 | 1,066 | $11K | |
| 87205 | 4,893 | 3,726 | $11K | |
| 74174 | 92 | 80 | $11K | |
| 77336 | 300 | 117 | $11K | |
| 80069 | 2,789 | 1,768 | $10K | |
| 96411 | 466 | 231 | $10K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 14,486 | 10,265 | $10K |
| 80076 | 1,865 | 1,595 | $10K | |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 418 | 187 | $10K |
| 97116 | 1,215 | 581 | $10K | |
| 86160 | 2,106 | 865 | $9K | |
| 88300 | 716 | 577 | $9K | |
| 85730 | 2,982 | 2,242 | $9K | |
| 73110 | 224 | 180 | $8K | |
| 72141 | 130 | 101 | $8K | |
| 86803 | 1,031 | 883 | $8K | |
| 82043 | 2,330 | 2,045 | $8K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 27,095 | 16,778 | $8K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 246 | 241 | $8K |
| 82378 | 406 | 320 | $7K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 106 | 97 | $7K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 16,826 | 11,001 | $7K |
| 74022 | 117 | 105 | $7K | |
| 97166 | 259 | 215 | $7K | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 94 | 68 | $7K |
| 83050 | 1,761 | 1,321 | $7K | |
| 15004 | 35 | 30 | $7K | |
| 84450 | 2,558 | 2,123 | $7K | |
| 72040 | 170 | 156 | $7K | |
| 84460 | 2,578 | 2,134 | $6K | |
| 84156 | 3,126 | 2,510 | $6K | |
| 87340 | 1,147 | 918 | $6K | |
| 76770 | 209 | 181 | $6K | |
| 19083 | 13 | 12 | $6K | |
| 77300 | 46 | 37 | $6K | |
| 97161 | 275 | 185 | $6K | |
| 84100 | 2,669 | 1,575 | $6K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 11,104 | 8,267 | $6K |
| 86431 | 1,669 | 1,369 | $5K | |
| 84550 | 2,267 | 1,840 | $5K | |
| 85045 | 2,491 | 1,944 | $5K | |
| 84165 | 1,015 | 857 | $5K | |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | 214 | 176 | $5K |
| 97165 | 136 | 127 | $5K | |
| 90686 | 697 | 588 | $5K | |
| 87420 | 421 | 338 | $4K | |
| D2330 | 309 | 98 | $4K | |
| 76830 | Ultrasound, transvaginal | 63 | 58 | $4K |
| 70496 | 60 | 52 | $4K | |
| 88112 | 251 | 166 | $4K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 5,838 | 3,654 | $4K |
| 70498 | 77 | 65 | $4K | |
| 86003 | 1,519 | 110 | $4K | |
| 82657 | 247 | 191 | $4K | |
| 87116 | 586 | 447 | $4K | |
| 77080 | 159 | 120 | $4K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 70 | 53 | $4K |
| D1120 | Prophylaxis - child | 500 | 429 | $4K |
| 85018 | 2,131 | 1,273 | $3K | |
| 86225 | 454 | 371 | $3K | |
| 86334 | 371 | 306 | $3K | |
| 94010 | 104 | 87 | $3K | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 89 | 71 | $3K |
| 87206 | 1,652 | 691 | $3K | |
| A9270 | Non-covered item or service | 8,746 | 5,131 | $3K |
| 83615 | 817 | 620 | $3K | |
| 82040 | 1,399 | 1,140 | $3K | |
| J2785 | Injection, regadenoson, 0.1 mg | 2,251 | 1,881 | $3K |
| 88173 | 146 | 121 | $3K | |
| 73590 | 84 | 66 | $3K | |
| J7050 | Infusion, normal saline solution, 250 cc | 10,074 | 3,902 | $3K |
| 64450 | 34 | 24 | $3K | |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 2,108 | 1,757 | $3K |
| 87015 | 997 | 686 | $3K | |
| 86147 | 207 | 143 | $3K | |
| 96416 | 24 | 12 | $2K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 455 | 229 | $2K |
| 85014 | 2,461 | 1,427 | $2K | |
| 87102 | 694 | 545 | $2K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 12 | 12 | $2K |
| 86255 | 321 | 218 | $2K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 257 | 208 | $2K |
| 86769 | 92 | 86 | $2K | |
| 88313 | 99 | 54 | $2K | |
| 82044 | 825 | 727 | $2K | |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 1,537 | 1,259 | $2K |
| 70491 | 16 | 13 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 14,816 | 11,214 | $2K |
| J9045 | Injection, carboplatin, 50 mg | 412 | 207 | $2K |
| J0185 | Injection, aprepitant, 1 mg | 48 | 33 | $2K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 10,258 | 7,489 | $2K |
| 74230 | 95 | 79 | $2K | |
| 90662 | 555 | 435 | $2K | |
| 83516 | 236 | 129 | $2K | |
| 90935 | Hemodialysis procedure with single evaluation by a physician | 18 | 13 | $2K |
| 93246 | 142 | 105 | $2K | |
| 64447 | 25 | 15 | $2K | |
| 99490 | Ccm add 20min | 141 | 128 | $2K |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 107 | 89 | $2K |
| 95816 | 30 | 24 | $2K | |
| 74220 | 27 | 27 | $2K | |
| 84480 | 159 | 141 | $2K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 4,642 | 2,902 | $2K |
| 84146 | 119 | 86 | $2K | |
| 84155 | 978 | 829 | $2K | |
| 82947 | 615 | 498 | $1K | |
| 73120 | 27 | 25 | $1K | |
| D1208 | Topical application of fluoride, excluding varnish | 491 | 420 | $1K |
| J2550 | Injection, promethazine hcl, up to 50 mg | 3,090 | 2,192 | $1K |
| 86200 | 265 | 194 | $1K | |
| 93299 | 114 | 109 | $1K | |
| 72170 | 29 | 24 | $1K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 15,313 | 10,166 | $1K |
| 20610 | 15 | 13 | $1K | |
| 77417 | 855 | 325 | $1K | |
| 88360 | 90 | 41 | $1K | |
| 74019 | 14 | 14 | $1K | |
| 72131 | 13 | 12 | $1K | |
| 93280 | 88 | 83 | $1K | |
| 88172 | 13 | 12 | $1K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 63 | 51 | $1K |
| J1170 | Injection, hydromorphone, up to 4 mg | 9,875 | 5,869 | $1K |
| 95806 | 42 | 40 | $1K | |
| 74178 | 12 | 12 | $1K | |
| 82784 | 167 | 78 | $984.89 | |
| C1769 | Guide wire | 3,072 | 2,260 | $974.62 |
| 86738 | 64 | 61 | $888.30 | |
| 75574 | 15 | 15 | $879.70 | |
| 71270 | 12 | 12 | $875.34 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 2,659 | 1,858 | $867.70 |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 16 | 12 | $852.75 |
| 87075 | 248 | 188 | $829.48 | |
| 85613 | 198 | 146 | $815.08 | |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | 2,769 | 2,261 | $801.59 |
| 93289 | 43 | 40 | $750.42 | |
| 83519 | 60 | 45 | $736.08 | |
| 93288 | 58 | 44 | $731.70 | |
| D3220 | Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction | 38 | 14 | $724.00 |
| J2704 | Injection, propofol, 10 mg | 14,205 | 10,769 | $719.17 |
| 82150 | 156 | 121 | $676.38 | |
| 87081 | 118 | 89 | $640.26 | |
| 82962 | 276 | 110 | $616.59 | |
| 93985 | 18 | 17 | $590.01 | |
| 86706 | 130 | 111 | $581.62 | |
| 97760 | 12 | 12 | $536.12 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 4,174 | 2,417 | $528.49 |
| 75710 | 20 | 13 | $507.62 | |
| 73070 | 14 | 14 | $501.15 | |
| 88341 | 4,089 | 836 | $492.19 | |
| C1725 | Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) | 275 | 214 | $449.55 |
| C1768 | Graft, vascular | 118 | 103 | $444.30 |
| 82805 | 15 | 14 | $439.16 | |
| J0640 | Injection, leucovorin calcium, per 50 mg | 79 | 38 | $435.00 |
| P9045 | Infusion, albumin (human), 5%, 250 ml | 30 | 25 | $429.27 |
| 72110 | 13 | 12 | $427.70 | |
| 86677 | 29 | 26 | $422.72 | |
| J9267 | Injection, paclitaxel, 1 mg | 115 | 38 | $385.05 |
| G0379 | Direct admission of patient for hospital observation care | 44 | 36 | $368.00 |
| 81241 | 22 | 14 | $350.10 | |
| 86300 | 15 | 14 | $346.95 | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 2,690 | 1,936 | $346.09 |
| 87046 | 28 | 26 | $343.41 | |
| 92611 | 76 | 65 | $338.40 | |
| 83020 | 36 | 28 | $321.29 | |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | 160 | 142 | $315.68 |
| 96376 | 5,122 | 2,461 | $313.24 | |
| 81240 | 21 | 13 | $300.32 | |
| 86256 | 47 | 42 | $291.77 | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 23 | 13 | $276.08 |
| D0210 | Intraoral - complete series of radiographic images | 292 | 248 | $268.74 |
| 84403 | 13 | 12 | $250.64 | |
| 0296T | 13 | 13 | $234.38 | |
| 86039 | 45 | 39 | $228.44 | |
| 51702 | 13 | 12 | $220.84 | |
| 85651 | 157 | 134 | $201.04 | |
| C9290 | Injection, bupivacaine liposome, 1 mg | 944 | 700 | $200.74 |
| 83883 | 32 | 13 | $192.84 | |
| 99495 | 32 | 25 | $188.49 | |
| 87088 | 30 | 23 | $183.27 | |
| 87045 | 28 | 26 | $180.29 | |
| 77061 | 22 | 14 | $163.54 | |
| 86762 | 17 | 13 | $161.85 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 10,662 | 8,141 | $155.89 |
| G0444 | Annual depression screening, 5 to 15 minutes | 305 | 265 | $137.17 |
| 90656 | 15 | 15 | $117.70 | |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 48 | 37 | $113.90 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 8,613 | 5,706 | $105.69 |
| 85598 | 19 | 15 | $97.58 | |
| C9113 | Injection, pantoprazole sodium, per vial | 2,082 | 949 | $96.62 |
| 80177 | 14 | 13 | $95.44 | |
| G0008 | Administration of influenza virus vaccine | 1,004 | 835 | $92.91 |
| J1171 | Injection, hydromorphone, 0.1 mg | 201 | 156 | $88.28 |
| 82140 | 15 | 12 | $84.42 | |
| C1730 | Catheter, electrophysiology, diagnostic, other than 3d mapping (19 or fewer electrodes) | 40 | 29 | $81.12 |
| 99497 | 114 | 93 | $75.31 | |
| J0136 | Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg | 982 | 851 | $74.45 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 4,167 | 2,713 | $73.71 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 2,378 | 2,014 | $59.55 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 6,482 | 2,420 | $56.85 |
| J9190 | Injection, fluorouracil, 500 mg | 131 | 38 | $52.08 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 243 | 183 | $51.31 |
| 85660 | 15 | 12 | $47.48 | |
| 76937 | 183 | 121 | $43.66 | |
| 84630 | 50 | 38 | $41.21 | |
| 74300 | 108 | 88 | $41.03 | |
| 82009 | 13 | 12 | $40.68 | |
| 94729 | 268 | 223 | $36.78 | |
| 82310 | 13 | 13 | $36.12 | |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 913 | 639 | $34.25 |
| J8540 | Dexamethasone, oral, 0.25 mg | 62 | 39 | $31.27 |
| 81000 | 26 | 24 | $30.96 | |
| Q9969 | Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose | 150 | 147 | $30.00 |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 248 | 224 | $28.95 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 202 | 164 | $26.83 |
| 96368 | 273 | 152 | $26.36 | |
| 89051 | 12 | 12 | $25.20 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 10,141 | 5,814 | $24.61 |
| 84145 | 439 | 311 | $24.12 | |
| 81003 | 12 | 12 | $23.42 | |
| J1940 | Injection, furosemide, up to 20 mg | 2,052 | 1,188 | $17.52 |
| C1781 | Mesh (implantable) | 107 | 78 | $14.47 |
| A9541 | Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries | 252 | 180 | $12.72 |
| J1644 | Injection, heparin sodium, per 1000 units | 5,159 | 2,927 | $11.12 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 405 | 372 | $8.12 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 17 | 14 | $7.28 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 1,999 | 1,514 | $7.08 |
| J2720 | Injection, protamine sulfate, per 10 mg | 14 | 12 | $7.01 |
| Q4100 | Skin substitute, not otherwise specified | 82 | 66 | $6.71 |
| J1956 | Injection, levofloxacin, 250 mg | 229 | 166 | $6.60 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 1,394 | 909 | $5.29 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 123 | 92 | $5.23 |
| J0134 | Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg | 66 | 55 | $5.07 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 230 | 148 | $4.54 |
| J3370 | Injection, vancomycin hcl, 500 mg | 730 | 325 | $2.62 |
| 90715 | 894 | 790 | $2.61 | |
| J3480 | Injection, potassium chloride, per 2 meq | 59 | 37 | $2.56 |
| J0736 | Injection, clindamycin phosphate, 300 mg | 65 | 49 | $2.31 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 3,236 | 2,240 | $2.02 |
| Q9950 | Injection, sulfur hexafluoride lipid microspheres, per ml | 499 | 220 | $1.96 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 17 | 13 | $1.74 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 1,206 | 1,003 | $1.03 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 1,950 | 1,626 | $0.92 |
| J2060 | Injection, lorazepam, 2 mg | 326 | 242 | $0.45 |
| 77063 | Screening digital breast tomosynthesis, bilateral | 529 | 469 | $0.43 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 344 | 227 | $0.03 |
| C1776 | Joint device (implantable) | 51 | 30 | $0.00 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 1,123 | 897 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 108 | 90 | $0.00 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 1,165 | 947 | $0.00 |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 88 | 70 | $0.00 |
| Q9961 | High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml | 84 | 71 | $0.00 |
| J1953 | Injection, levetiracetam, 10 mg | 19 | 13 | $0.00 |
| C1760 | Closure device, vascular (implantable/insertable) | 17 | 12 | $0.00 |
| A9537 | Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries | 14 | 12 | $0.00 |
| 93356 | 38 | 27 | $0.00 | |
| G8996 | Swallowing functional limitation, current status at therapy episode outset and at reporting intervals | 46 | 38 | $0.00 |
| J0694 | Injection, cefoxitin sodium, 1 gm | 30 | 25 | $0.00 |
| G8997 | Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 47 | 39 | $0.00 |
| 97150 | Therapeutic procedure(s), group (2 or more individuals) | 20 | 12 | $0.00 |
| 77062 | 47 | 26 | $0.00 | |
| A6010 | Collagen based wound filler, dry form, sterile, per gram of collagen | 14 | 13 | $0.00 |
| A9504 | Technetium tc-99m apcitide, diagnostic, per study dose, up to 20 millicuries | 20 | 17 | $0.00 |
| D0220 | Intraoral - periapical first radiographic image | 13 | 12 | $0.00 |
| 76942 | 16 | 12 | $0.00 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 17 | 12 | $0.00 |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 317 | 68 | $0.00 |
| J3490 | Unclassified drugs | 342 | 256 | $0.00 |
| A9609 | Fludeoxyglucose f18 up to 15 millicuries | 262 | 243 | $0.00 |
| J1815 | Injection, insulin, per 5 units | 39 | 30 | $0.00 |
| A9503 | Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries | 355 | 334 | $0.00 |
| G0009 | Administration of pneumococcal vaccine | 99 | 82 | $0.00 |
| J7121 | 5% dextrose in lactated ringers infusion, up to 1000 cc | 61 | 26 | $0.00 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 151 | 85 | $0.00 |
| J1920 | Injection, labetalol hydrochloride, 5 mg | 29 | 19 | $0.00 |
| G8998 | Swallowing functional limitation, discharge status, at discharge from therapy or to end reporting | 28 | 26 | $0.00 |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 224 | 207 | $0.00 |
| 11045 | 101 | 42 | $0.00 | |
| J2470 | Injection, pantoprazole sodium, 40 mg | 53 | 37 | $0.00 |
| A4648 | Tissue marker, implantable, any type, each | 54 | 40 | $0.00 |
| 97802 | 26 | 16 | $0.00 | |
| J0280 | Injection, aminophyllin, up to 250 mg | 15 | 12 | $0.00 |
| A9540 | Technetium tc-99m macroaggregated albumin, diagnostic, per study dose, up to 10 millicuries | 16 | 12 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 153 | 113 | $0.00 |